These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 381315)

  • 1. Potentiation of the chemotherapeutic action of 5-fluorouracil by combination with cytidine or guanosine on HRS-sarcoma.
    Osswald H; Youssef M
    J Cancer Res Clin Oncol; 1979 Apr; 93(3):241-4. PubMed ID: 381315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of the chemotherapeutic action of bleomycin by combination with inosine on HRS-sarcoma.
    Osswald H; Youssef M
    Cancer Lett; 1975 Sep; 1(1):55-8. PubMed ID: 65212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pyrimidines, purines and their nucleosides on antitumor activity of 5-fluorouracil against L-1210 leukemia.
    Iigo M; Ando N; Hoshi A; Kuretani K
    J Pharmacobiodyn; 1982 Jul; 5(7):515-20. PubMed ID: 7131236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system.
    Iigo M; Kuretani K; Hoshi A
    Cancer Res; 1983 Dec; 43(12 Pt 1):5687-94. PubMed ID: 6640523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the chemotherapeutic effect of 5-fluorouracil by combination with guanosine 5'-monophosphate.
    Iigo M; Nakajima Y; Kuretani K; Hoshi A
    Gan; 1983 Apr; 74(2):291-8. PubMed ID: 6305753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia.
    Iigo M; Hoshi A
    Cancer Chemother Pharmacol; 1984; 13(2):86-90. PubMed ID: 6235977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and experimental results of interstitial Brachy-Curie-therapy combined with radiation sensitizing agents in infiltrative growing brain neoplasms].
    Mundinger F; Vogt P; Jobski C; Fischer HU; Ostertag C
    Strahlentherapie; 1972 Mar; 143(3):318-28. PubMed ID: 5053646
    [No Abstract]   [Full Text] [Related]  

  • 8. [The kinetics of reticulosarcomatosis development in mice and the effect of chemotherapeutic preparations].
    Dronova LM; Belich EI; Erokhin VN
    Izv Akad Nauk SSSR Biol; 1976; (1):140-4. PubMed ID: 767388
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of serotonin, 5-fluorouracil and prednisolone on the phagocytic response of neutrophils in rats with sarcoma-45].
    Shipovskaia LA; Mal'tseva LF
    Farmakol Toksikol; 1975; 38(1):77-9. PubMed ID: 1112399
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of coadministration of thymine or thymidine on the antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil.
    Fujii S; Kitano S; Ikenaka K; Fukushima M; Nakamura H; Maehara Y; Shirasaka T
    Gan; 1980 Feb; 71(1):100-6. PubMed ID: 6769735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of the chemotherapeutic action of 5'-deoxy-5-fluorouridine in combination with guanosine and related compounds.
    Iigo M; Miwa M; Ishitsuka H; Nitta K
    Cancer Chemother Pharmacol; 1987; 19(1):61-4. PubMed ID: 3028664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo.
    Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA
    Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of antitumor activity of 1-phthalidyl 5-fluorouracil by acetazolamide.
    Kasai H; Tonda K; Hirata M
    Cancer Chemother Pharmacol; 1986; 16(1):55-7. PubMed ID: 3940220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of antimetabolite antitumor activity in vivo by dipyridamole and amphotericin B.
    Cao SS; Zhen YS
    Cancer Chemother Pharmacol; 1989; 24(3):181-6. PubMed ID: 2736709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of the antitumor effect of 5-fluorouracil by some nucleotides, and their possible role in the potentiation.
    Tezuka M; Tamemasa O
    Jpn J Exp Med; 1983 Jun; 53(3):155-63. PubMed ID: 6663806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the lengthening of the survival time of RF mice with retothelial sarcoma by the combination of radiotherapy and chemotherapy].
    Woenckhaus HJ; Klemm D; Obrecht P
    Klin Wochenschr; 1965 Jul; 43(14):793-4. PubMed ID: 4953435
    [No Abstract]   [Full Text] [Related]  

  • 17. [Potentiation of chemotherapeutic activity by a Chinese herb medicine juzen-taiho-toh].
    Komiyama K; Hirokawa Y; Zhibo Y; Umezawa I; Hata T
    Gan To Kagaku Ryoho; 1988 May; 15(5):1715-9. PubMed ID: 3130806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of the antitumor action of 5-fluorouracil with 5-ethyl-2'-deoxyuridine in human colorectal tumor xenografts.
    Kopper L; Magyarosy E; Jeney A; Lapis K; Szabolcs A; Otvös L
    Oncology; 1984; 41(3):155-8. PubMed ID: 6328393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [BOF-A1 and BOF-A2, new 5-FU degradation-inhibitory agents].
    Fujii S
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2244-50. PubMed ID: 2955745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined action of serotonin, prednisolone and 5-fluorouracil on sarcoma 45 and M-1].
    Muratova GP; Mal'tseva LF; Rudzit EA
    Vopr Onkol; 1974; 20(2):57-60. PubMed ID: 4439792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.